» Articles » PMID: 37957292

An Umbrella Review of Candidate Predictors of Response, Remission, Recovery, and Relapse Across Mental Disorders

Abstract

We aimed to identify diagnosis-specific/transdiagnostic/transoutcome multivariable candidate predictors (MCPs) of key outcomes in mental disorders. We conducted an umbrella review (protocol  link ), searching MEDLINE/Embase (19/07/2022), including systematic reviews of studies reporting on MCPs of response, remission, recovery, or relapse, in DSM/ICD-defined mental disorders. From published predictors, we filtered MCPs, validating MCP criteria. AMSTAR2/PROBAST measured quality/risk of bias of systematic reviews/individual studies. We included 117 systematic reviews, 403 studies, 299,888 individuals with mental disorders, testing 796 prediction models. Only 4.3%/1.2% of the systematic reviews/individual studies were at low risk of bias. The most frequently targeted outcome was remission (36.9%), the least frequent was recovery (2.5%). Studies mainly focused on depressive (39.4%), substance-use (17.9%), and schizophrenia-spectrum (11.9%) disorders. We identified numerous MCPs within disorders for response, remission and relapse, but none for recovery. Transdiagnostic MCPs of remission included lower disease-specific symptoms (disorders = 5), female sex/higher education (disorders = 3), and quality of life/functioning (disorders = 2). Transdiagnostic MCPs of relapse included higher disease-specific symptoms (disorders = 5), higher depressive symptoms (disorders = 3), and younger age/higher anxiety symptoms/global illness severity/ number of previous episodes/negative life events (disorders = 2). Finally, positive trans-outcome MCPs for depression included less negative life events/depressive symptoms (response, remission, less relapse), female sex (response, remission) and better functioning (response, less relapse); for schizophrenia, less positive symptoms/higher depressive symptoms (remission, less relapse); for substance use disorder, marital status/higher education (remission, less relapse). Male sex, younger age, more clinical symptoms and comorbid mental/physical symptoms/disorders were poor prognostic factors, while positive factors included social contacts and employment, absent negative life events, higher education, early access/intervention, lower disease-specific and comorbid mental and physical symptoms/conditions, across mental disorders. Current data limitations include high risk of bias of studies and extraction of single predictors from multivariable models. Identified MCPs can inform future development, validation or refinement of prediction models of key outcomes in mental disorders.

Citing Articles

Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife).

Glaus J, Karow A, Lambert M, Sowada P, Brockel-Bundt K, Berndt C Int J Bipolar Disord. 2025; 13(1):7.

PMID: 39964389 PMC: 11836254. DOI: 10.1186/s40345-025-00373-y.


Modelling the impact of environmental and social determinants on mental health using generative agents.

Kambeitz J, Meyer-Lindenberg A NPJ Digit Med. 2025; 8(1):36.

PMID: 39820048 PMC: 11739565. DOI: 10.1038/s41746-024-01422-z.


Neurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder.

Iftimovici A, Krebs E, Dalfin W, Legrand A, Scoriels L, Martinez G Psychol Med. 2024; :1-12.

PMID: 39402801 PMC: 11536111. DOI: 10.1017/S0033291724001776.


Innovative strategies for managing hallucinations by exploring effects of tDCS on source monitoring abilities.

Sharma G, Chitturi V, Sharma V, Kathrotia R, Barde P, Parmar N Sci Rep. 2024; 14(1):16569.

PMID: 39019949 PMC: 11254933. DOI: 10.1038/s41598-024-67279-0.


Clinical utility of the at-risk for psychosis state beyond transition: A multidimensional network analysis.

Boldrini T, Lo Buglio G, Cerasti E, Pontillo M, Muzi L, Salcuni S Eur Child Adolesc Psychiatry. 2024; 34(1):287-296.

PMID: 38896144 PMC: 11805795. DOI: 10.1007/s00787-024-02491-x.


References
1.
Kohler C, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L . Mapping risk factors for depression across the lifespan: An umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018; 103:189-207. DOI: 10.1016/j.jpsychires.2018.05.020. View

2.
Jaaskelainen E, Juola P, Hirvonen N, McGrath J, Saha S, Isohanni M . A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2012; 39(6):1296-306. PMC: 3796077. DOI: 10.1093/schbul/sbs130. View

3.
Rosson S, de Filippis R, Croatto G, Collantoni E, Pallottino S, Guinart D . Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review. Neurosci Biobehav Rev. 2022; 139:104743. DOI: 10.1016/j.neubiorev.2022.104743. View

4.
. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022; 9(2):137-150. PMC: 8776563. DOI: 10.1016/S2215-0366(21)00395-3. View

5.
Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg E . The Science of Prognosis in Psychiatry: A Review. JAMA Psychiatry. 2018; 75(12):1289-1297. DOI: 10.1001/jamapsychiatry.2018.2530. View